Reaction

Epstein-Barr Viraemia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,073 reports · 55 co-occurring drugs

As of the last recalculation, Epstein-Barr Viraemia appears in 1,073 FAERS reports alongside 55 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-THYMOCYTE GLOBULIN (RABBIT) (PRR 256.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Anti-Thymocyte Globulin (Rabbit)	97	256.3	259.5
Ganciclovir	103	215.8	218.0
Ganciclovir Sodium	105	213.2	215.4
Fludarabine Phosphate	253	163.0	164.1
Valganciclovir Hydrochloride Powder,	76	130.0	130.8
Tacrolimus Ointment 0.1%	469	129.0	129.5
Tacrolimus Extended-Release Capsules	469	128.7	129.1
Tacrolimus	491	111.3	111.6
Valganciclovir	98	110.9	111.4
Valganciclovir Hydrochloride	98	110.9	111.4
Basiliximab	62	108.5	109.0
Busulfan	78	103.6	104.1
Alemtuzumab	90	98.4	98.9
Thiotepa	44	93.2	93.6
Melphalan	83	76.6	76.9
Sirolimus	50	75.5	75.7
Mycophenolate Mofetil	343	71.5	71.7
Mycophenolate Mofetil Hydrochloride	343	71.4	71.6
Melphalan Hydrochloride	85	71.3	71.6
Mycophenilic Acid	57	56.3	56.4
Anakinra	43	52.3	52.5
Cyclosporine	215	46.6	46.7
Everolimus Tablets	35	41.8	41.9
Mycophenolic Acid	64	41.2	41.3
Cyclophosphamide Injection, Solution	231	32.0	32.0
Cyclophosphamide	231	32.0	32.0
Cyclophosphamide For Injection	231	32.0	32.0
Mesna Injection	12	28.5	28.5
Mesna	12	27.9	28.0
Rituximab	223	25.6	25.6
Budesonide	69	24.2	24.2
Methylprednisolone	128	20.3	20.3
Itraconazole	12	20.1	20.2
Posaconazole Delayed-Release	11	19.6	19.6
Cytarabine	55	18.7	18.7
Prednisolone	145	17.9	17.9
Prednisolone Oral	145	17.9	17.9
Prednisolone Oral Solution	145	17.9	17.9
Brentuximab Vedotin	9	17.2	17.2
Micafungin Sodium	7	16.1	16.1
Everolimus	35	13.8	13.8
Eculizumab	37	13.6	13.7
Posaconazole	11	13.3	13.3
Ruxolitinib	46	13.0	13.0
Etoposide	46	12.6	12.6
Mercaptopurine	11	12.4	12.4
Thalidomide	19	10.2	10.2
Bleomycin Sulfate	5	9.4	9.4
Remdesivir	6	8.8	8.8
Bendamustine Hydrochloride	5	8.1	8.1
Doxorubicin	36	8.1	8.1
Blinatumomab	4	7.5	7.5
Ofatumumab	11	6.5	6.5
Azacitidine For	6	6.4	6.4
Axicabtagene Ciloleucel	3	5.9	5.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.